Nifty
Sensex
:
:
15752.05
52907.93
-28.20 (-0.18%)
-111.01 (-0.21%)

Chemicals

Rating :
44/99

BSE: 530019 | NSE: JUBLPHARMA

338.75
01-Jul-2022
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  • 348.80
  • 349.00
  • 281.80
  • 343.70
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  71858
  •  239.46
  •  767.00
  •  281.80

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 5,394.85
  • 13.10
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 7,307.51
  • 1.48%
  • 1.02

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 50.68%
  • 2.72%
  • 19.27%
  • FII
  • DII
  • Others
  • 23.45%
  • 0.05%
  • 3.83%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.54
  • 8.73
  • -0.76

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.83
  • 7.05
  • 1.69

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 49.73
  • 7.45
  • 12.81

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 14.71
  • 14.40
  • 13.49

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.11
  • 2.17
  • 1.79

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 8.69
  • 8.25
  • 7.32

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Var%
Dec 21
Dec 20
Var%
Sep 21
Sep 20
Var%
Jun 21
Jun 20
Var%
Net Sales
1,527.53
1,579.78
-3.31%
1,310.53
1,771.34
-26.01%
1,657.45
1,591.35
4.15%
1,634.65
1,156.07
41.40%
Expenses
1,280.18
1,205.16
6.22%
1,116.29
1,278.58
-12.69%
1,317.95
1,241.57
6.15%
1,259.41
976.76
28.94%
EBITDA
247.35
374.62
-33.97%
194.24
492.76
-60.58%
339.50
349.78
-2.94%
375.24
179.31
109.27%
EBIDTM
16.19%
23.71%
14.82%
27.82%
20.48%
21.98%
22.96%
15.51%
Other Income
-2.96
6.69
-
5.91
3.59
64.62%
4.45
3.45
28.99%
3.89
3.91
-0.51%
Interest
39.51
43.34
-8.84%
36.62
46.37
-21.03%
34.74
46.46
-25.23%
34.62
47.93
-27.77%
Depreciation
100.55
86.24
16.59%
93.33
95.94
-2.72%
99.78
85.09
17.26%
88.04
81.68
7.79%
PBT
104.33
241.39
-56.78%
70.20
343.15
-79.54%
209.43
221.68
-5.53%
256.47
53.61
378.40%
Tax
46.58
83.06
-43.92%
19.43
121.16
-83.96%
65.40
74.78
-12.54%
86.02
18.22
372.12%
PAT
57.75
158.33
-63.53%
50.77
221.99
-77.13%
144.03
146.90
-1.95%
170.45
35.39
381.63%
PATM
3.78%
10.02%
3.87%
12.53%
8.69%
9.23%
10.43%
3.06%
EPS
3.74
13.44
-72.17%
3.20
19.46
-83.56%
8.97
14.06
-36.20%
10.09
5.52
82.79%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Net Sales
6,130.16
8,905.51
9,154.41
9,110.82
7,517.84
5,861.43
5,749.13
5,826.25
5,803.36
5,165.95
4,303.13
Net Sales Growth
0.52%
-2.72%
0.48%
21.19%
28.26%
1.95%
-1.32%
0.39%
12.34%
20.05%
 
Cost Of Goods Sold
1,488.00
3,002.49
3,140.58
3,521.84
2,862.51
2,002.74
2,116.20
2,663.02
2,438.46
2,062.85
1,618.87
Gross Profit
4,642.16
5,903.02
6,013.84
5,588.98
4,655.33
3,858.69
3,632.94
3,163.23
3,364.90
3,103.10
2,684.26
GP Margin
75.73%
66.29%
65.69%
61.34%
61.92%
65.83%
63.19%
54.29%
57.98%
60.07%
62.38%
Total Expenditure
4,973.83
7,014.43
7,207.34
7,371.81
5,999.45
4,516.14
4,502.19
5,124.71
4,782.37
4,097.81
3,412.94
Power & Fuel Cost
-
105.79
112.21
466.38
424.91
333.66
366.71
393.04
389.74
356.73
286.89
% Of Sales
-
1.19%
1.23%
5.12%
5.65%
5.69%
6.38%
6.75%
6.72%
6.91%
6.67%
Employee Cost
-
2,172.83
2,127.68
1,925.96
1,555.88
1,230.93
1,125.09
1,090.28
1,105.17
962.58
836.36
% Of Sales
-
24.40%
23.24%
21.14%
20.70%
21.00%
19.57%
18.71%
19.04%
18.63%
19.44%
Manufacturing Exp.
-
449.40
362.15
552.26
485.98
428.84
436.46
432.40
405.14
360.48
329.75
% Of Sales
-
5.05%
3.96%
6.06%
6.46%
7.32%
7.59%
7.42%
6.98%
6.98%
7.66%
General & Admin Exp.
-
387.92
416.80
540.75
354.56
280.98
256.23
302.28
264.23
208.35
200.72
% Of Sales
-
4.36%
4.55%
5.94%
4.72%
4.79%
4.46%
5.19%
4.55%
4.03%
4.66%
Selling & Distn. Exp.
-
177.15
194.71
267.70
247.85
185.79
135.54
203.98
160.04
123.28
111.85
% Of Sales
-
1.99%
2.13%
2.94%
3.30%
3.17%
2.36%
3.50%
2.76%
2.39%
2.60%
Miscellaneous Exp.
-
718.85
853.22
96.92
67.76
53.20
65.96
39.72
19.59
23.53
111.85
% Of Sales
-
8.07%
9.32%
1.06%
0.90%
0.91%
1.15%
0.68%
0.34%
0.46%
0.66%
EBITDA
1,156.33
1,891.08
1,947.07
1,739.01
1,518.39
1,345.29
1,246.94
701.54
1,020.99
1,068.14
890.19
EBITDA Margin
18.86%
21.23%
21.27%
19.09%
20.20%
22.95%
21.69%
12.04%
17.59%
20.68%
20.69%
Other Income
11.29
29.84
47.43
35.74
40.03
24.86
13.37
42.45
19.06
29.87
31.48
Interest
145.49
247.29
287.41
219.81
284.28
341.11
371.35
367.61
337.11
310.93
238.23
Depreciation
381.70
451.65
461.93
370.90
415.05
291.40
346.74
287.95
281.17
253.79
220.65
PBT
640.43
1,221.99
1,245.17
1,184.04
859.08
737.64
542.22
88.43
421.78
533.29
462.79
Tax
217.43
376.40
312.29
326.80
224.66
163.02
155.40
80.48
69.64
152.36
68.41
Tax Rate
33.95%
31.35%
25.80%
36.16%
26.15%
22.10%
28.66%
199.55%
33.60%
44.66%
59.95%
PAT
423.00
824.62
898.24
574.46
642.81
575.66
391.83
-57.76
109.04
152.73
14.56
PAT before Minority Interest
423.92
824.36
898.24
577.01
634.42
574.63
386.82
-40.16
137.64
188.78
45.69
Minority Interest
0.92
0.26
0.00
-2.55
8.39
1.03
5.01
-17.60
-28.60
-36.05
-31.13
PAT Margin
6.90%
9.26%
9.81%
6.31%
8.55%
9.82%
6.82%
-0.99%
1.88%
2.96%
0.34%
PAT Growth
-24.81%
-8.20%
56.36%
-10.63%
11.66%
46.92%
-
-
-28.61%
948.97%
 
EPS
26.55
51.77
56.39
36.06
40.35
36.14
24.60
-3.63
6.84
9.59
0.91

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Shareholder's Funds
4,741.49
5,603.88
4,808.92
4,086.53
3,436.04
2,966.26
2,453.52
2,626.51
2,476.12
2,257.03
Share Capital
15.92
15.93
15.93
15.58
15.57
15.54
15.93
15.45
15.93
15.93
Total Reserves
4,724.75
5,587.95
4,792.94
4,070.78
3,419.98
2,950.72
2,437.59
2,611.07
2,460.19
2,241.10
Non-Current Liabilities
2,973.05
4,087.52
4,420.21
3,417.47
3,826.06
3,347.13
4,036.15
2,184.95
3,004.85
3,224.12
Secured Loans
20.78
728.92
811.65
729.88
1,581.96
2,620.41
3,316.29
1,716.67
1,708.74
2,839.47
Unsecured Loans
2,543.19
3,010.76
3,431.24
2,317.93
1,923.07
392.79
375.00
0.22
760.06
0.45
Long Term Provisions
94.01
150.75
114.35
107.08
80.69
70.31
67.04
219.53
237.96
169.70
Current Liabilities
1,048.83
2,619.01
2,089.73
2,004.69
1,684.04
2,464.44
2,129.16
3,894.41
2,778.35
2,212.79
Trade Payables
520.48
1,090.27
1,020.13
1,136.16
749.49
612.12
721.19
718.14
647.13
836.98
Other Current Liabilities
371.73
674.21
473.57
505.87
572.70
951.43
793.31
1,731.20
898.00
499.55
Short Term Borrowings
20.00
649.89
499.71
244.85
255.60
748.97
517.17
1,187.83
1,131.39
767.07
Short Term Provisions
136.62
204.64
96.31
117.81
106.24
151.93
97.49
257.25
101.84
109.18
Total Liabilities
8,763.40
12,310.41
11,318.96
9,457.17
8,898.75
8,739.70
8,618.83
8,863.81
8,370.86
7,762.89
Net Block
4,608.75
6,339.97
5,648.38
5,400.55
5,106.73
5,104.42
4,911.33
5,098.78
4,967.46
4,460.18
Gross Block
6,089.57
7,982.83
6,905.50
6,288.86
5,672.38
5,390.82
7,362.10
7,330.63
6,870.15
6,084.09
Accumulated Depreciation
1,480.83
1,642.85
1,257.12
888.31
565.66
286.40
2,450.76
2,231.85
1,902.69
1,623.92
Non Current Assets
5,810.90
7,272.06
6,734.16
6,267.41
5,950.63
5,864.37
5,904.29
5,935.78
5,809.80
5,465.57
Capital Work in Progress
896.99
768.39
901.43
670.97
683.78
611.32
596.60
472.39
436.89
685.55
Non Current Investment
240.96
69.36
115.11
123.52
102.71
85.43
39.50
33.99
25.61
19.20
Long Term Loans & Adv.
62.84
86.81
68.59
71.79
56.32
62.67
327.17
328.42
379.47
299.86
Other Non Current Assets
1.35
7.53
0.66
0.58
1.08
0.53
29.68
2.21
0.37
0.79
Current Assets
2,952.50
5,038.35
4,584.80
3,189.76
2,948.12
2,875.32
2,714.54
2,928.03
2,561.06
2,297.32
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
1,129.38
1,845.38
1,417.39
1,391.39
1,220.40
1,203.10
1,235.33
1,341.42
1,116.18
1,020.22
Sundry Debtors
819.90
1,293.22
1,271.55
1,130.76
1,005.30
950.50
819.27
805.87
708.54
652.69
Cash & Bank
671.32
1,399.87
1,370.41
248.79
459.63
344.58
394.34
479.53
356.05
266.82
Other Current Assets
331.90
419.59
485.64
373.06
262.79
377.13
265.59
301.21
380.29
357.59
Short Term Loans & Adv.
89.53
80.29
39.80
45.75
37.06
133.06
144.56
136.04
182.01
256.70
Net Current Assets
1,903.67
2,419.34
2,495.07
1,185.06
1,264.08
410.88
585.38
-966.38
-217.29
84.53
Total Assets
8,763.40
12,310.41
11,318.96
9,457.17
8,898.75
8,739.69
8,618.83
8,863.81
8,370.86
7,762.89

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Cash From Operating Activity
1,784.27
1,542.94
1,121.51
1,303.20
1,268.49
1,098.89
783.26
772.27
969.90
707.17
PBT
1,212.01
1,210.53
903.81
859.08
737.64
542.22
40.32
207.28
341.14
114.11
Adjustment
716.48
760.74
861.53
687.81
637.90
737.89
725.84
756.60
752.36
795.44
Changes in Working Capital
249.90
-179.67
-300.53
14.15
36.88
-133.16
96.40
-110.70
-4.04
-136.91
Cash after chg. in Working capital
2,178.39
1,791.60
1,464.82
1,561.04
1,412.42
1,146.96
862.57
853.18
1,089.46
772.64
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-394.12
-248.66
-343.31
-257.84
-143.94
-48.07
-79.31
-80.91
-119.56
-65.47
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-739.01
-327.00
-1,011.84
-617.70
-450.39
-312.53
-343.33
-174.42
-499.72
-594.31
Net Fixed Assets
2,198.22
-241.66
-305.67
-147.58
-115.33
785.60
1,162.43
-166.96
-286.05
-434.15
Net Investments
118.05
-0.14
-57.59
3.34
-0.39
57.01
239.81
-27.56
-18.79
-95.66
Others
-3,055.28
-85.20
-648.58
-473.46
-334.67
-1,155.14
-1,745.57
20.10
-194.88
-64.50
Cash from Financing Activity
-1,709.39
-1,050.37
657.43
-901.13
-685.87
-842.75
-502.69
-414.41
-449.76
-888.82
Net Cash Inflow / Outflow
-664.13
165.56
767.10
-215.63
132.22
-56.38
-62.76
183.44
20.41
-775.95
Opening Cash & Equivalents
1,230.81
1,005.40
244.18
456.44
339.27
391.64
473.49
279.65
263.08
1,041.15
Closing Cash & Equivalent
501.96
1,230.81
1,005.40
244.18
456.44
339.27
391.63
473.49
279.65
263.08

Financial Ratios

Consolidated /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Book Value (Rs.)
297.84
351.83
301.93
262.33
220.61
190.90
154.04
170.07
155.46
141.70
ROA
7.82%
7.60%
5.55%
6.91%
6.52%
4.46%
-0.46%
1.60%
2.34%
0.60%
ROE
15.94%
17.25%
12.97%
16.87%
17.95%
14.27%
-1.58%
5.39%
7.98%
2.06%
ROCE
16.49%
15.07%
13.06%
15.21%
14.44%
12.42%
5.72%
7.92%
10.19%
5.79%
Fixed Asset Turnover
1.27
1.23
1.38
1.26
1.09
0.92
0.81
0.84
0.82
0.78
Receivable days
43.30
51.13
48.12
51.58
59.43
54.81
49.56
46.53
47.00
48.71
Inventory Days
60.96
65.05
56.26
63.07
73.64
75.51
78.58
75.51
73.76
71.07
Payable days
97.91
58.75
55.42
56.86
54.84
53.44
52.17
51.42
45.33
38.70
Cash Conversion Cycle
6.36
57.43
48.96
57.79
78.23
76.88
75.98
70.61
75.42
81.08
Total Debt/Equity
0.55
0.83
1.01
0.85
1.18
1.51
1.95
1.67
1.71
1.69
Interest Cover
5.86
5.21
5.11
4.02
3.16
2.46
1.11
1.61
2.10
1.48

News Update:


  • Jubilant Pharmova’s arm inks pact with US Government to expand critical vaccine manufacturing capacity
    30th May 2022, 10:45 AM

    This agreement is in addition to the $92 million filling line expansion announced in November 2021, which will be commercially available by the end of 2024

    Read More
  • Jubilant Pharmova enters into agreements to acquire stake in SPV Laboratories
    4th Apr 2022, 14:38 PM

    Aggregate cost of acquisition is Rs 8.75 crore for acquiring 25.21% stake

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.